IU Health is seeking a patient-focused Malignant Hematologist to join our Multiple Myeloma practice in Indianapolis, IN!

• Full-time employment opportunity for adult, multiple myeloma patients
• 100% clinical
• 80% outpatient / 20% inpatient
• Expected patient volume in clinic: 40/week
• Expected patient volume on inpatient: 20/week
• Monday - Friday, 12 weekends of call annually
• Practice locations include Eskenazi Hospital, University Hospital, and IU Simon Cancer Center (all part of the IU School of Medicine's Academic Health Center)

Key Responsibilities

• Provide independent judgement in diagnosis and treatment of patients, formulation of treatment plans, and direction of the interdisciplinary team in achieving the goals of the patient care plan

Qualifications

• MD or DO with BE/BC in Hematology
• Subspecialty expertise & demonstrated clinical excellence in Multiple Myeloma & plasma cell disorders
• Excellent communication, interpersonal, & collaborative skills
• Only open to practicing physicians at this time

Community Description

• Leading educational system and top-ranked universities, paired with a diverse population
• Vibrant downtown offering arts, theaters, world-class museums, zoo, concerts and memorials
• Named to U.S. News & World Report's 2023-2024 list of the best places to live in the United States
• Top ranked international airport: " Best Airport in North America " twelve consecutive years
• Ranked by Niche in 2023 as one of the most diverse counties in America, as well as one of the best cities to live in and buy a house in the country
• Historic neighborhoods with surrounding cultural districts and low cost of living
• Outdoor recreation includes golfing, boating and unique parks
• Home of the Colts ( NFL ), Fever ( WNBA ), Pacers ( NBA ), Indians ( MiLB ), Indianapolis 500 ( IndyCar ) and the nation's largest half marathon
• Close proximity to Chicago, St. Louis, Louisville, and Cincinnati

Healthcare System/Hospital Description

The

Healthcare providers at IU Health Melvin and Bren Simon Cancer Center not only offer the highest level of patient care but many are engaged in research. As the only National Cancer Institute (NCI)-designated cancer center in the state of Indiana, IU Health Simon Cancer Center’s researchers are recognized for meeting rigorous criteria for world-class, state-of-the-art programs in multidisciplinary cancer research. NCI-designated canc er centers put significant resources into developing research programs, faculty and facilities that will lead to better approaches to prevention, diagnosis and treatment of cancer.

In 2022, the IU Health Melvin and Bren Simon Cancer Center was admitted as a member of the National Comprehensive Cancer Network, an alliance of 32 leading cancer centers devoted to patient care, research and education.

The mission is to advance the understanding, prevention and treatment of cancer throughout Indiana and the world with patient-centered care, acceleration of promising science and collaborative educational programs. Research is vigorous, innovative and devoted to taking improved cancer care into the future. In all, more than 200 physicians, nurses, social workers, techologists and researchers are working to develop cures for cancer.

That teamwork leads to clinical breakthroughs, such as turning the cure rate of testicular cancer from 10 percent to nearly 95 percent today, among many others. The benefits to patients are clear: a wide range of innovative treatment options, expert teams of diverse professionals focused on their specific cancer type, and attention to all cancer care needs in one setting.